Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?
Efficace
Fabio
F
Novik
Andrei
A
Vignetti
Marco
M
Mandelli
Franco
F
Cleeland
Charles S
CS
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D004341:Drug Evaluation / Q000523:psychology / Q000639:trends; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D006801:Humans; D010358:Patient Participation / Q000523:psychology / Q000639:trends; D011788:Quality of Life / Q000523:psychology; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents